Document Detail


A multimodal, β-amyloid-targeted contrast agent.
MedLine Citation:
PMID:  23139935     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
A multimodal, β-amyloid-targeted contrast agent was synthesized and studied in vitro. The agent has a higher relaxivity than a clinically approved contrast agent and interacts with β-amyloid aggregates producing changes in relaxation rate and fluorescence emission.
Authors:
Sashiprabha M Vithanarachchi; Matthew J Allen
Related Documents :
8293765 - Modulation of vascular cyclic nucleotide phosphodiesterases by cyclic gmp: role in vaso...
181685 - Effects of stimulatory and depressant drugs on cyclic guanosine 3',5'-monophosphate and...
2844755 - Stereochemical course of the reaction catalyzed by the cyclic gmp phosphodiesterase fro...
25289355 - A new economic method for preparing platelet-rich plasma.
6892135 - Effect of hypophysectomy and starvation on the fine structure of vitellogenic oocytes i...
1705945 - Immunohistochemical localization of vitronectin, its receptor and beta-3 integrin in al...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-11-9
Journal Detail:
Title:  Chemical communications (Cambridge, England)     Volume:  -     ISSN:  1364-548X     ISO Abbreviation:  Chem. Commun. (Camb.)     Publication Date:  2012 Nov 
Date Detail:
Created Date:  2012-11-9     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9610838     Medline TA:  Chem Commun (Camb)     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Department of Chemistry, Wayne State University, 5101 Cass Avenue, Detroit, MI 48202, USA. mallen@chem.wayne.edu.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A biocatalytic hydrogenation of carboxylic acids.
Next Document:  Activation of molecular oxygen by a metal-organic framework with open 2,2'-bipyridine for selective ...